| 000 | 01105 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513233025.0 | ||
| 264 | 0 | _c20010614 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a1351-8216 | ||
| 024 | 7 |
_a10.1046/j.1365-2516.2001.00096.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEwenstein, B M | |
| 245 | 0 | 0 |
_aUse of ristocetin cofactor activity in the management of von Willebrand disease. _h[electronic resource] |
| 260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _cJan 2001 |
||
| 300 |
_a10-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiological Assay |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aFactor VIII _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRistocetin |
| 650 | 0 | 4 |
_avon Willebrand Diseases _xblood |
| 650 | 0 | 4 |
_avon Willebrand Factor _xtherapeutic use |
| 773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 7 Suppl 1 _gp. 10-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2516.2001.00096.x _zAvailable from publisher's website |
| 999 |
_c11177740 _d11177740 |
||